| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 18 |
| 1 | NIVOLUMAB | 14 |
| 2 | CARBOPLATIN | 10 |
| 3 | IBUPFROFEN | 9 |
| 4 | IBUPROFEN | 9 |
| 5 | IBUPROFEN 200 MG | 9 |
| 6 | IBUPROFEN 200MG | 9 |
| 7 | IBUPROFEN CAPSULE | 9 |
| 8 | IBUPROFEN CAPSULES 200 MG | 9 |
| 9 | IBUPROFEN ORAL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NALDEMEDINE | 3 | 0.0018 |
| 1 | CROTAMITON | 1 | 0.0016 |
| 2 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 3 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 4 | GLYCERIN SUPPOSITORY | 2 | 0.0008 |
| 5 | GLYCERIN SUPPOSITORIES | 2 | 0.0007 |
| 6 | SUGAMMADEX | 2 | 0.0007 |
| 7 | ENFORTUMAB VEDOTIN | 4 | 0.0005 |
| 8 | CAPMATINIB | 1 | 0.0004 |
| 9 | REMIFENTANIL HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 | 0.0004 |
| 1 | Melatonin Receptor Agonist [EPC] | 3 | 0.0002 |
| 2 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 6 | Non-Standardized Plant Allergenic Extract [EPC] | 2 | 0.0001 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |